WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and Wheeler Bio, Inc., a contract development and manufacturing organization (CDMO), today announced an ...
WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it acquired of Distributed Bio, Inc. on December 31, 2020. The acquisition marks ...
Citi upgraded Bio-Rad Laboratories (NYSE:BIO) to buy while downgrading Hologic (NASDAQ:HOLX) to neutral and Charles River Laboratories (NYSE:CRL) to sell as part of its Q3 earnings preview on the ...
RightSource SM is Charles River's insourced, purpose-built lab offering that provides industry-leading expertise conveniently placed within a Wheeler Bio's new cGMP drug substance facility. OKLAHOMA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results